# Sonogenetics is a new modality using ultrasound to precisely control specific cells ‘tagged’ with special proteins.

*biotech · news · 2026-04-07 · The Manila Times*

## Key points

- SonoNeu has emerged from stealth to commercialize sonogenetics as a drug-free therapeutic platform.
- The ARPA-H awarded up to $41.3 million for a six-year, multi-institution sonogenetics research collaboration.
- Sonogenetics enables precise, noninvasive control of specific cells using ultrasound-responsive proteins.
- The project aims to develop wearable ultrasound devices paired with engineered proteins for targeted therapy.
- Sonogenetics could provide non-invasive brain-computer interfaces and deep brain stimulation without implants.

**Companies:** SonoNeu, General Inception
**Countries:** United States

[Read the full story on The Manila Times](https://www.manilatimes.net/2026/04/07/tmt-newswire/globenewswire/sononeu-exits-stealth-as-key-part-of-us-government-funded-research-program-worth-up-to-413m-to-advance-sonogenetics-into-clinic/2315153)

---

Canonical: https://newsio.io/n/085d0d76-d3b8-469f-86c0-f05b81c44e37/sonogenetics-is-a-new-modality-using-ultrasound-to-precisely-control-specific-ce
Summarized by Newsio from The Manila Times. https://newsio.io/how-it-works